| Bioactivity | Ritalinic acid (Ritalinate) is the main inactive urinary metabolite of Methylphenidate. Methylphenidate has the potential for attention-deficit hyperactivity disorder and narcolepsy research[1]. | ||||||||||||
| Name | Ritalinic acid | ||||||||||||
| CAS | 19395-41-6 | ||||||||||||
| Formula | C13H17NO2 | ||||||||||||
| Molar Mass | 219.28 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Ricardo Jorge Dinis-Oliveira, et al. Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects. Eur J Drug Metab Pharmacokinet. 2017 Feb;42(1):11-16. |
Ritalinic acid
CAS: 19395-41-6 F: C13H17NO2 W: 219.28
Ritalinic acid (Ritalinate) is the main inactive urinary metabolite of Methylphenidate. Methylphenidate has the potentia
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.